18F-DOPA and 18F-FDG PET/CT in Sporadic Medullary Thyroid Cancer: washout rate of 18F-DOPA, between early and late scans, correlated with Calcitonin and CEA doubling time and positive FDG PET/CT

被引：0
|
作者：
Ghedini, P. [1 ]
Repaci, A. [2 ]
Cervati, V. [1 ]
Salituro, N. [2 ]
Mora, L. [1 ]
Malizia, C. [1 ]
Lodi, F. [1 ]
Castellucci, P. [1 ]
Ambrosini, V. [1 ]
Nanni, C. [1 ]
Pagotto, U. [2 ]
Fanti, S. [1 ]
机构：
[1] Univ Bologna, S Orsola Malpighi Hosp, Metropolitan Nucl Med, Bologna, Italy
[2] St Orsola Marcello Malpighi Hosp, DIMEC, Endocrinol Unit, Bologna, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-144
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [41] Which is the optimal acquisition time of 18F-DOPA PET/CT for the detection of recurrent medullary thyroid cancer?
    Lanni, V.
    Castaldi, P.
    Indovina, L.
    Stefanelli, A.
    Scolozzi, V.
    Giordano, A.
    Rufini, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S316 - S316
  • [42] Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma
    B. Beuthien-Baumann
    A. Strumpf
    J. Zessin
    J. Bredow
    J. Kotzerke
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1604 - 1609
  • [43] Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma
    Beuthien-Baumann, B.
    Strumpf, A.
    Zessin, J.
    Bredow, J.
    Kotzerke, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) : 1604 - 1609
  • [44] Prognostic Value of Interim 18F-DOPA and 18F-FDG PET/CT Findings in Stage 3-4 Pediatric Neuroblastoma
    Ko, Kuan-Yin
    Yen, Ruoh-Fang
    Ko, Chi-Lun
    Chou, Shu-Wei
    Chang, Hsiu-Hao
    Yang, Yung-Li
    Jou, Shiann-Tarng
    Hsu, Wen-Ming
    Lu, Meng-Yao
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : 21 - 25
  • [45] Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT
    Calabria, Ferdinando
    Chiaravalloti, Agostino
    Di Pietro, Barbara
    Grasso, Cristina
    Schillaci, Orazio
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (06) : 563 - 570
  • [46] 18F-DOPA PET/CT in Localization of Persistent/Recurrent MTC
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) : 16N - 17N
  • [47] Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism
    Dunia Ismail
    Khalid Hussain
    Reviews in Endocrine and Metabolic Disorders, 2010, 11 : 165 - 169
  • [48] 18F-DOPA PET/CT: Diagnosis of a synchronous appendiceal neuroendocrine tumor in a patient with medullary thyroid cancer
    Amaya, J.
    Repetto, A.
    Rubi, S.
    Fuster, J.
    Martinez, M.
    Garcia-Granero, A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 338 - 339
  • [49] A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancer
    Treglia, Giorgio
    Stefanelli, Antonella
    Castaldi, Paola
    Rufini, Vittoria
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (02) : 185 - 186
  • [50] Multi-tracer PET/CT with 18F-DOPA, 68Ga-somatostatin analogues and 18F-FDG in patients with recurrent medullary thyroid carcinoma: preliminary results
    Treglia, G.
    Castaldi, P.
    Villani, M. F.
    Filice, A.
    Ambrosini, V.
    Salvo, D.
    Fanti, S.
    Rufini, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S302 - S302
12345